News
Video
Podcasts
Journals
Conferences
Events
Resources
CE
About AJMC
Subscribe

Spotlight -

Free In-Person Regional Events Focused on Oncology and Population Health

Peter S. Staats, MD, MBA

Articles by Peter S. Staats, MD, MBA

Concomitant Medical Conditions and Total Cost of Care in Patients With Migraine: A Real-World Claims Analysis

ByMichael Polson, PharmD, MS,Ted D. Williams, PharmD, BCPS,Lindsay C. Speicher, JD,Mkaya Mwamburi, MD, PhD, MA,Peter S. Staats, MD, MBA,Andrew T. Tenaglia, BA

February 18th 2020

Real-World Assessment of Concomitant Opioid Utilization and Associated Trends in Patients With Migraine

ByAnne Kangethe, PharmD, PhD, RPh, MPH,Michael Polson, PharmD, MS,Themmi M. Evangelatos, PharmD, MSBA,Lindsay C. Speicher, JD,Andrew T. Tenaglia, BA,Peter S. Staats, MD, MBA,Eric J. Liebler,Mkaya Mwamburi, MD, PhD, MA

February 18th 2020

Patient Experience With Non-Invasive Vagus Nerve Stimulator: gammaCore Patient Registry

ByMkaya Mwamburi, MD, PhD, MA,Eric J. Liebler,Peter S. Staats, MD, MBA

February 18th 2020

Review of Evidence on Noninvasive Vagus Nerve Stimulation for Treatment of Migraine: Efficacy, Safety, and Implications

ByMkaya Mwamburi, MD, PhD,Andrew T. Tenaglia, BA,Eric J. Leibler,Peter S. Staats, MD, MBA

December 13th 2018

Noninvasive Vagus Nerve Stimulation in a Primary Care Setting: Effects on Quality of Life and Utilization Measures in Multimorbidity Patients With or Without Primary Headache

ByIain Strickland, PhD, BSc,Mkaya Mwamburi, MD, PhD,Steven Davis BSc,James C.R. Ward, MBBS,Janet Day, MBChB,Andrew T. Tenaglia, BA,Eric J. Leibler,Peter S. Staats, MD, MBA

December 13th 2018

Cost-effectiveness of Noninvasive Vagus Nerve Stimulation for Acute Treatment of Episodic Migraine and Role in Treatment Sequence Strategies

ByMkaya Mwamburi, MD, PhD,Andrew T. Tenaglia, BA,Eric J. Leibler,Peter S. Staats, MD, MBA

December 13th 2018

Latest Updated Articles

Review of Evidence on Noninvasive Vagus Nerve Stimulation for Treatment of Migraine: Efficacy, Safety, and Implications
Published: December 13th 2018 | Updated:
Noninvasive Vagus Nerve Stimulation in a Primary Care Setting: Effects on Quality of Life and Utilization Measures in Multimorbidity Patients With or Without Primary Headache
Published: December 13th 2018 | Updated:
Cost-effectiveness of Noninvasive Vagus Nerve Stimulation for Acute Treatment of Episodic Migraine and Role in Treatment Sequence Strategies
Published: December 13th 2018 | Updated:
Concomitant Medical Conditions and Total Cost of Care in Patients With Migraine: A Real-World Claims Analysis
Published: February 18th 2020 | Updated:
Real-World Assessment of Concomitant Opioid Utilization and Associated Trends in Patients With Migraine
Published: February 18th 2020 | Updated:
Patient Experience With Non-Invasive Vagus Nerve Stimulator: gammaCore Patient Registry
Published: February 18th 2020 | Updated:

Trending on AJMC

House Votes to Extend ACA Subsidies, Eyes Turn to Senate

5 Key Health Care Changes During Trump’s First Year Back in Office

Maternal Morbidity Increased in States Enacting TRAP Laws

Proteomic Biomarkers Hold Promise in IPF

Unmet Needs in HER2-Mutant NSCLC

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

© 2025 MJH Life Sciences^®

All rights reserved.